APA (7th ed.) Citation

C, L., ML, T., HY, C., TM, C., CM, S., ATH, W., . . . FL, M. (2026). Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection. Journal of nanobiotechnology, 24(1), 41. https://doi.org/10.1186/s12951-025-04012-7

Chicago Style (17th ed.) Citation

C, Lin, et al. "Pathology-tailored Nanotherapy via Galectin-3-targeted and Triple-responsive Nanoparticles Enables Multimodal Therapy Against Aortic Dissection." Journal of Nanobiotechnology 24, no. 1 (2026): 41. https://doi.org/10.1186/s12951-025-04012-7.

MLA (9th ed.) Citation

C, Lin, et al. "Pathology-tailored Nanotherapy via Galectin-3-targeted and Triple-responsive Nanoparticles Enables Multimodal Therapy Against Aortic Dissection." Journal of Nanobiotechnology, vol. 24, no. 1, 2026, p. 41, https://doi.org/10.1186/s12951-025-04012-7.